Chongqing BDSyn Biotechnology Co., Ltd.
BDSyn Biotech is an innovative biotechnology company specializing in the research, development, and production of vaccine adjuvants. With globally leading adjuvant industrialization technologies, the company has successfully developed structurally defined QS-21 Api and monophosphoryl lipid A (MPL) series products. It supplies both traditional adjuvants (e.g., aluminum hydroxide) and novel adjuvant systems (e.g., BDS01–BDS08). Additionally, BDSyn provides comprehensive technical and product services, including adjuvant raw materials, formulated adjuvant preparations, and adjuvant screening. Committed to technological innovation, BDSyn is dedicated to delivering high-performance and safe adjuvant solutions for global vaccine manufacturers.